Copy
header

JULY 2017

TOP NEWS

UChicago medical oncologist Rita Nanda, MD, presents data from the I-SPY 2 trial.

Immunotherapy drug effective in triple-negative breast cancer

In the I-SPY 2 clinical trial, adding the checkpoint blocker pembrolizumab (KeytrudaTM) to standard therapy dramatically improved response rates for patients with invasive triple-negative breast cancer, tumors that lack estrogen and progesterone receptors, as well as HER2, which is a protein that promotes the growth of cancer cells. “The results observed in this trial are not only encouraging, but game changing,” said medical oncologist Rita Nanda, MD, associate professor of medicine at the University of Chicago.

Read More >>
 

Dr. Pitroda with Theresa Barrett

Radiosurgery becoming treatment of choice for spinal metastases

Spinal radiosurgery is becoming a standard of care for spinal tumors. The emerging technique is proving highly effective for Theresa Barrett, a eight-year breast cancer survivor who has recurring, sometimes painful spinal metastases. By delivering high-dose treatments to small areas, radiosurgery is currently the best way to treat spinal tumors, says Sean Pitroda, MD, of UChicago’s Ludwig Center for Metastasis Research.

Read More >>

Robert Grossman (r) discusses data with Dean Kenneth Polonsky (middle). 

Harnessing big data to cure cancer

Genomic Data Commons (GDC), housed at UChicago, is one of the largest open access repositories for cancer data in the world. In this Chicago Inno interview, GDC's principal investigator Robert Grossman talks about how the project has fared in its first year, next generation data commons, and how big data can help cure cancer.

Read More >>

 

DONOR SPOTLIGHT

John Cacioppo, PhD, and Stephanie Cacioppo, PhD

Giving and the strength of social connection

To Stephanie and John Cacioppo, both behavioral neuroscience faculty at the University of Chicago, giving back is at the heart of their extensive research on perceived social isolation and social connection. Two years ago, the issue became personal when John was diagnosed with advanced head and neck cancer.

Read More >> 
 

FACULTY SPOTLIGHT

Thomas Gajewski, MD, PhD

Thomas Gajewski named a 2017 Giant of Cancer Care

Thomas Gajewski, MD, PhD, professor of medicine and pathology at the University of Chicago, has been named one of 12 “Giants of Cancer Care for 2017” by OncLive®, an organization that offers oncology professionals information they can use in patient care through their publications and videos. Gajewski is the fourth University of Chicago physician to win this honor since it began in 2013.

Read More >>
 

UPCOMING EVENTS

Chicago Kicking Cancer Kickball Tournament

Chicago Kicking Cancer Kickball Tournament
Saturday, August 19, 2017
Winnemac Park, Chicago
10 a.m.

The 2017 Simon M. Shubitz Cancer Lecture
Monday, September 25, 2017
Knapp Center for Biomedical Discovery

900 E. 57th Street, Lecture Hall 1103
Noon
 

Simon M. Shubitz Award Ceremony and Annual Foundation Dinner
Monday, September 25, 2017
The Four Seasons Hotel
Chicago, IL
6 p.m.

UCCRF Women's Board
Annual Grand Auction
Saturday, November 11, 2017
The Four Seasons Hotel
Chicago, IL
6:30 p.m.
 
Facebook
Twitter
Website
Share
Tweet
Forward






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
The University of Chicago Medicine and Biological Sciences · 130 East Randolph Street · Suite 2500 · Chicago, IL 60601 · USA